Chengdu Kanghua Biological Products (300841) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Chengdu Kanghua Biological Products (300841) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥92.89 Million ≈ $13.59 Million USD) by net assets (CN¥3.51 Billion ≈ $513.14 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Chengdu Kanghua Biological Products - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chengdu Kanghua Biological Products's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Chengdu Kanghua Biological Products carry for a breakdown of total debt and financial obligations.

Chengdu Kanghua Biological Products Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chengdu Kanghua Biological Products ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Yunnan Hongxiang Yixintang SHE:002727	0.071x
Meitav Dash Investments Ltd TA:MTDS	0.074x
Hengerda New Materials (Fujian) Co. Ltd. SHE:300946	N/A
Primax Electronics Ltd TW:4915	0.039x
Collegium Pharmaceutical Inc NASDAQ:COLL	0.285x
TRANSFORMERS AND RECTIFIERS INDIA NSE:TARIL	-0.021x
TRUSTPILOT GROUP LS -01 F:6VZ	N/A
International General Insurance Holdings Ltd NASDAQ:IGIC	0.004x

Annual Cash Flow Conversion Efficiency for Chengdu Kanghua Biological Products (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chengdu Kanghua Biological Products from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Chengdu Kanghua Biological Products (300841) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥3.45 Billion ≈ $504.48 Million	CN¥572.24 Million ≈ $83.74 Million	0.166x	+1.62%
2023-12-31	CN¥3.51 Billion ≈ $514.22 Million	CN¥573.98 Million ≈ $83.99 Million	0.163x	+157.64%
2022-12-31	CN¥3.08 Billion ≈ $450.07 Million	CN¥194.99 Million ≈ $28.53 Million	0.063x	+29.90%
2021-12-31	CN¥2.67 Billion ≈ $390.75 Million	CN¥130.33 Million ≈ $19.07 Million	0.049x	-73.93%
2020-12-31	CN¥1.97 Billion ≈ $288.92 Million	CN¥369.56 Million ≈ $54.08 Million	0.187x	-41.14%
2019-12-31	CN¥574.65 Million ≈ $84.09 Million	CN¥182.73 Million ≈ $26.74 Million	0.318x	+103.86%
2018-12-31	CN¥367.70 Million ≈ $53.81 Million	CN¥57.35 Million ≈ $8.39 Million	0.156x	-67.34%
2017-12-31	CN¥188.37 Million ≈ $27.56 Million	CN¥89.96 Million ≈ $13.16 Million	0.478x	+1838.25%
2016-12-31	CN¥-96.21 Million ≈ $-14.08 Million	CN¥2.64 Million ≈ $386.80K	-0.027x	+56.55%
2015-12-31	CN¥-102.87 Million ≈ $-15.05 Million	CN¥6.51 Million ≈ $951.92K	-0.063x	--

About Chengdu Kanghua Biological Products

SHE:300841 China Biotechnology

Market Cap

$1.09 Billion

CN¥7.42 Billion CNY

Market Cap Rank

#8757 Global

#2306 in China

Share Price

CN¥57.08

Change (1 day)

-0.90%

52-Week Range

CN¥52.31 - CN¥92.06

All Time High

CN¥399.08